CompletedNot Applicable

Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study

Egypt40 participantsStarted 2021-12-01

Plain-language summary

Current prenatal diagnosis of placenta accrete spectrum disorders relies on subjective individual interpretations of visual sonographic findings on grayscale and color Doppler imaging. When blinded to clinical data, there is significant interobserver variability in the diagnosis of invasive placentation. This study will evaluate placental thickness among pregnant women with placenta previa and determine if increased placenta thickness correlates with the risk for placenta accreta spectrum (PAS) disorders.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women with ultrasound diagnosis of placenta previa or low lying placenta * Gestational age above 26 weeks * singleton pregnancy * fetal life positive * Past history of cesarean section regardless of the number Exclusion Criteria: * Hemodynamically unstable women. * Patients with pregestational or gestational DM. * Multiple gestation. * Medical disorders which can lead to uteroplacental insufficiency (preeclampsia - SLE - antiphospholipid antibody syndrome). * Any condition which can lead to enlarged placenta such as fetal hydrops

What they're measuring

Placental thickness threshold

Timeframe: after 26 weeks of pregnancy

Trial details

NCT IDNCT05500404

SponsorAin Shams Maternity Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-08-31

View on ClinicalTrials.gov More Placenta Accreta Spectrum trials